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 Stem cells hold great promise in tissue engineering for repairing tissues damaged by disease or injury. 
Mesenchymal stem cells (MSCs) are multipotent cells able to proliferate and differentiate into multiple meso-
dermal tissues such as bone, cartilage, muscle, tendon, and fat. We have previously reported that the low-affi nity 
nerve growth factor receptor (L-NGFR or CD271) defi nes a subset of cells with high proliferative, clonogenic, and 
multipotential differentiation ability in adult bone marrow (BM). It has been recently shown that adipose tissue 
is an alternative source of adult multipotent stem cells and human adipose-derived stem cells, selected by plastic 
adherence (PA hASCs), have been extensively characterized for their functional potentials in vitro. In this study, 
immunoselected L-NGFR + and CD34 + subpopulations have been analyzed and compared with the PA hASCs. 
Phenotypic profi le of freshly purifi ed subpopulations showed an enrichment in the expression of some stem 
cell markers; indeed, a great percentage of L-NGFR + cells co-expressed CD34 and CD117 antigens, whereas the 
endothelial-committed progenitor markers KDR and P1H12 were mainly expressed on CD34 + cells. Differently 
from PA hASCs, the immunoseparated fractions showed high increments in cell proliferation, and the fi broblast 
colony-forming activity (CFU-F) was maintained throughout the time of culture. Furthermore, the immunose-
lected populations showed a greater differentiative potential toward adipocytes, osteoblasts, and chondrocyte-
like cells, compared to PA hASCs. Our data suggest that both CD34 + and L-NGFR + hASCs can be considered 
alternative candidates for tissue engineering and regenerative medicine applications. 
 Introduction 
 In the recent years, the emerging fi eld of cell-based ther-apies for repair and regeneration of damaged tissues has 
been focusing on the identifi cation of the ideal source of 
stem cells, which combines the ability of multipotential dif-
ferentiation and the accessibility in large amounts under a 
minimally invasive procedure, not complicated by immuno-
logical rejection concerns and ethical controversies. 
 Adult mesenchymal stem cells (MSCs) are a population 
of multipotent cells able to proliferate and differentiate into 
multiple mesodermal tissues. MSCs have been initially iden-
tifi ed in bone marrow (BM) [ 1 ], but have been subsequently 
isolated from many other tissues [ 2–10 ]. Among them, human 
MSCs derived from adipose tissue (hASCs) show stem cell 
key features such as the ability to form fi broblast-like col-
onies (CFU-F), the expression of several common cell sur-
face antigens, the capacity of extensive proliferation, and the 
potential to differentiate in vitro and in vivo into multiple 
lineages of mesodermal origin, and also to transdifferenti-
ate into neurogenic and hepatic lineages [ 4 , 11–21 ]. Similarly 
to BM-derived MSCs (BM MSCs), hASCs are able to sup-
press immunoreactivity, suggesting a possible overcoming 
of histocompatibility limitations in allogeneic transplanta-
tion [ 22 , 23 ]; furthermore, they are easily accessible in large 
amounts by liposuction [ 4 , 24 , 25 ]. Several studies have dem-
onstrated the effi cacy of these cells in clinical applications; in 
particular, the cell-assisted lipotransfer technique has been 
successfully used for the treatment of facial lipoatrophy 
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of DMEM (Sigma-Aldrich, Milan, Italy) supplemented with 
10% FBS (fetal bovine serum; Lonza, Milan, Italy), 50 U/mL 
penicillin (Sigma-Aldrich), 50 μg/mL streptomycin (Sigma-
Aldrich), and 2 mM  l -glutamine (Sigma-Aldrich) and then 
counted. Cells were either plated in control medium at a 
density of 10 5 cells/cm 2 to select the progenitor cells by plas-
tic adherence (PA hASCs) or immunoselected by L-NGFR 
and CD34 MoAbs as described below. 
 Positive selection of CD34 + and L-NGFR + hASCs 
 Positive selection of CD34 + and L-NGFR + cells was per-
formed using the Direct CD34 Progenitor Cell Isolation Kit 
and the CD271 Microbead Kit, respectively (Miltenyi Biotech, 
Calderara di Reno, Italy), according to the manufacturers’ 
instructions. Cells were then counted and assessed for via-
bility; their purity was determined by fl ow cytometry. 
 Flow cytometry analysis 
 To analyze the expression of specifi c surface markers, 2 × 
10 5 hASCs were incubated with the following anti-human pri-
mary MoAbs: CD34-FITC (8G12), CD117-APC (YB5B8), CD45-
PerCP (2D1) (Becton Dickinson, Milan, Italy), AC133/2-PE 
and AC133-APC (293C3) (CD133) (Miltenyi Biotech), CD146-
FITC and -PE (P1H12; Chemicon International Inc., Temecula, 
CA), CD105-FITC (SN6; Serotec Inc., Raleigh, NC), NGFR-PE 
(C40-1457; BD PharMingen, Milan, Italy), KDR-APC (89106; 
R&D Systems, Minneapolis, MN) and glycophorin A-FITC 
(Immunotech SAS, Marseille, France). Samples were then 
evaluated by FACSCanto II Instrument and Diva software 
(Becton Dickinson). 
 hASCs cultures 
 After the isolation, PA, CD34 + , and L-NGFR + hASCs were 
cultured in control medium at 37°C in a humidifi ed atmo-
sphere (5% CO 2 ), with weekly refeeds. Cells were grown until 
90% confl uency, detached by 0.25% trypsin/1 mM EDTA 
(Sigma-Aldrich) for 5 min at 37°C, counted to assess their 
proliferation, and tested for CFU-F effi ciency and differenti-
ation potential; 10% of the collected cells were re-expanded. 
 MSCs progenitor assays 
 Colony-forming units-fi broblast (CFU-F) assay. The clono-
genic ability of PA, CD34 + , and L-NGFR + hASCs fractions 
was determined by a low-density CFU-F assay performed 
at different passages in culture [ 37 ]. The cells from the 3 
populations were resuspended in control medium supple-
mented with 20% FBS and seeded in 6-well plates at differ-
ent cellular density: 1-3-6-12-24-48 cells/cm 2 . After 5 days 
of culture, half of the medium was removed and replaced 
by fresh medium; after 9 days, the wells were rinsed with 
PBS, fi xed with methanol, and stained with Crystal Violet 
(Sigma-Aldrich). The colonies consisting of ≥50 cells were 
counted and the frequency of colonies was expressed on 1 
× 10 3 plated cells. 
 Hematopoietic progenitor assays. The colony-forming 
unit-granulocyte/macrophage (CFU-GM) and burst-form-
ing unit-erythroblast (BFU-E) assays were carried out by 
plating 1 × 10 5 CD34 + cells in a methylcellulose culture 
and breast augmentation [ 26 , 27 ] and a clinical trial is actu-
ally in progress to evaluate the effi cacy of the reimplanta-
tion of autologous hASCs purifi ed through the Celution ® 
system (Cytori Inc., San Diego, CA) for breast reconstruction. 
Moreover, 2 clinical trials (Phase I and Phase II, respectively) 
were recently performed using in vitro-expanded hASCs 
for the treatment of perianal fi stula [ 28 , 29 ], with satisfactory 
results. 
 These cells have been extensively characterized for their 
functional potential; however, the heterogeneity of the start-
ing cell population and the variability in stem cell recovery 
among different donors and subcutaneous adipose tissue 
depots [ 4 , 30–33 ] cause some diffi culties to reproduce and 
compare the results, underlining the need of specifi c mark-
ers able to identify primitive and multipotent adipose-de-
rived stem cells. 
 We have previously shown that monoclonal antibodies 
(MoAbs) to the low-affi nity nerve growth factor receptor 
(L-NGFR or CD271) stain primitive MSCs with high speci-
fi city and purity in adult BM, defi ning a subset of cells with 
higher clonogenic effi ciency, proliferative and differentiative 
potential in comparison to the whole MSCs population [ 34 ]. 
Furthermore, some authors have highlighted the presence of 
CD34 + cells in the freshly isolated stromal vascular fraction 
(SVF) from human adipose tissue [ 18 , 19 , 35 , 36 ]. Isolation of 
CD34 + /CD31 − cells has revealed that this population differ-
entiated in vitro into endothelial cells and promoted in vivo 
angiogenesis, participating in the revascularization of ische-
mic hind limbs of nude mice [ 18 ]. 
 In this study, we compare the whole hASCs population, 
purifi ed by plastic adherence (PA hASCs), with 2 immunose-
lected subpopulations (L-NGFR + and CD34 + hASCs), evalu-
ating their phenotypic stem cell profi le, their proliferative 
and clonogenic potential, and their ability to differentiate 
toward adipocytes, osteoblasts, and chondrocyte-like cells. 
 Our results show that L-NGFR + and CD34 + hASCs are 
2 distinct purifi ed populations, with a higher clonogenic 
and differentiative ability compared to the PA unselected 
population. 
 Materials and Methods 
 hASCs isolation 
 Subcutaneous adipose tissue was collected from 12 female 
patients (mean age: 40.4 ± 6.6 years, BMI < 30, without any 
pathological obesity) who underwent aesthetic liposuction 
of the abdomen (3–4 mm diameter hollow blunt cannula 
connected to the syringe) at the Plastic and Reconstructive 
Surgery Unit of the Galeazzi Orthopaedic Institute. All the 
procedures were approved by the internal IRB and were 
performed by a senior plastic surgeon of the institute; all 
patients gave their consent for the research use of the waste 
tissue deriving from surgical interventions. 
 Adipose stem cells were isolated as previously described 
[ 11 ]. In brief, the raw lipoaspirates (50–100 mL) were washed 
at least 3 times with phosphate-buffered saline (PBS) and 
the matrix was digested with 0.075% type I collagenase 
(Worthington, Lakewood, NJ) at 37°C with continuous agita-
tion for 30 min. The SVF was centrifuged (1,200 g , 10 min) and 
fi ltered through a sterile medication lint; the collected cells 
were centrifuged, resuspended in control medium consisting 
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 Differentiation increments were evaluated by one-sample 
Student’s  t -test. 
 Differences were considered statistically signifi cant at 
 P < 0.05. 
 Results 
 Enrichment of pluripotent stem cells in hASCs 
 We determined the mean percentage of CD34 + and 
L-NGFR + cells in the SVF derived from 8 donors by cytofl u-
orimetric analysis. The mean percentage of CD34 + cells was 
13.7% ± 19.5% and the purity after immunoseparation was 
82.6% ± 12.9% ( Fig. 1A ). The percentage of L-NGFR + cells 
was 4.4% ± 6.3% and the purity of the immunoselected pop-
ulation was 88.5% ± 10.6% ( Fig. 1A ). 
 Phenotype analysis 
 The freshly purifi ed L-NGFR + and CD34 + fractions con-
sisted of small round cells rapidly adhering to the plastic 
and expressing surface markers associated with a primi-
tive phenotype. Despite the high variability among donors, 
immunomagnetic separation allowed us to identify 2 dis-
tinct subpopulations: a high percentage of L-NGFR + cells 
co-expressed the stem markers CD34 (78% ± 10.6%), while 
CD117 and CD105 were variably expressed (45.9% ± 36.5% 
medium (MethoCult GF H4434; StemCell Technologies Inc., 
Vancouver, Canada). Triplicate dishes were incubated at 
37°C and 5% CO 2 in a fully humidifi ed atmosphere. After 14 
days of culture, aggregates formed by ≥50 cells were scored 
as colonies and counted. 
 Functional assays 
 Adipogenic differentiation. In order to induce adipogenic 
differentiation, 5 × 10 5 hASCs from the different fractions 
were cultured in hMSC Mesenchymal Stem Cell Adipogenic 
Differentiation Medium (Lonza) in T-25 fl asks, with weekly 
refeeds. After 21 days of culture, the cells were fi xed in 10% 
formalin for 10 min and stained with fresh Oil Red-O so-
lution (Sigma-Aldrich). Oil Red-O was extracted from the 
fi xed samples incubating for 10 min with 100% isopropanol. 
Absorbance was read at 490 nm with Wallac Victor II plate 
reader. 
 Osteogenic differentiation. In order to differentiate cells 
toward the osteogenic lineage, 2.5 × 10 5 hASCs from the 
3 populations were plated in T-25 fl asks and cultured in 
hMSC Mesenchymal Stem Cell Osteogenic Differentiation 
Medium (Lonza), with weekly refeeds [ 38 ]. After 21 days, 
cells were washed with PBS, fi xed with ice-cold ethanol 70% 
for 1 h, and stained with Alizarin Red S (40 mM, pH 4.1, 
Sigma-Aldrich) for 10 min in order to detect calcium depo-
sition [ 39 ]. Alizarin Red S was extracted incubating samples 
for 30 min with 10% w/v cetylpyridinium chloride in 0.1 M 
phosphate buffer (pH 7.0) [ 40 ]. Absorbance was read at 550 
nm with Wallac Victor II plate reader. 
 Chondrogenic differentiation. Chondrogenic differentia-
tion was induced in pellet culture conditions: 5 × 10 5 hASCs 
from the different fractions were centrifuged (500 g , 5 min) 
in a 15-mL centrifuge tube, the pellets were resuspended 
either in control or in chondrogenic medium consisting of 
DMEM supplemented with 1% FBS (Lonza), 50 U/mL peni-
cillin, 50 μg/mL streptomycin, and 2 mM  l -glutamine, 1 mM 
sodium pyruvate (Sigma-Aldrich), 0.15 mM  l -ascorbic acid-
2-phosphate (Sigma-Aldrich), 1× ITS (Sigma-Aldrich), 0.1 
μM dexamethasone (Sigma-Aldrich), and 10 ng/mL TGF-β1 
(Biosource-Invitrogen, Camarillo, CA) and then centrifuged 
again (500 g , 5 min); medium was changed twice a week. 
After 21 days, micromasses were digested overnight at 56°C 
by proteinase K (50 μg/mL in 100 mM K 2 HPO 4 , pH 8.0, fi nal 
digestion volume 100 μL; Sigma-Aldrich). Sulfated gly-
cosaminoglycans (GAGs) were then quantifi ed according to 
a modifi ed version of the dimethylmethylene blue (DMMB; 
Sigma-Aldrich) assay [ 41 ]. Absorbance was read at 655 nm 
and the GAGs content, expressed as μg GAGs/micromass, 
was determined using bovine trachea chondroitin-4-sulfate 
(Sigma-Aldrich) as standard. 
 GAGs content of each sample was normalized with 
respect to DNA measured by Hoechst 33258 fl uorescence 
assay (355 nm excitation–460 nm emission, Wallac Victor II 
plate reader) using salmon sperm DNA as standard. 
 Statistical analysis 
 The Student’s  t -test for paired data was used to test the 
probability of signifi cant differences between paired sam-
ples for variables with normal distribution. 
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 FIG. 1.  ( A ) Immunophenotype of fresh human adipose-
derived stem cells (hASCs) fractions, analyzed immedi-
ately after isolation (PA) or immunoselection (CD34 + and 
L-NGFR + ). ( B ) Modulation of CD34 and low-affi nity nerve 
growth factor receptor (L-NGFR) expression during cul-
ture in PA fractions. The 2 × 10 5 cells were stained with 
antibodies against specifi c surface markers and analyzed 
by FACSCanto II Instrument using DIVA software. Data are 
expressed as mean percentage ± SD ( n = 12). 
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became quite different: PA hASCs grew with a larger and 
fl atten shape, with cells gathered in clusters and cytoplasm 
rich in granules, in contrast to the immunoselected cells 
that still appeared homogeneous, spindle-shaped, and with 
well-defi ned shape and nuclei ( Fig. 4B ). 
 Hematopoietic progenitors evaluation 
 In order to investigate the presence of hematopoietic pro-
genitors within CD34 + fractions isolated from adipose tis-
sue, hematopoietic culture assays were performed to verify 
the ability of immunoselected CD34 + cells to form lineage-
committed hematopoietic progenitors, according to their 
growth in semisolid cultures: CFU-GM and BFU-E. 
 After 14 days of culture, we never observed hematopoietic 
progenitors growth in none of the samples analyzed ( n = 5): 
on methylcellulose medium, CD34 + cells always gave rise to 
a monolayer of cells with fi broblast-like morphology. 
 Differentiation ability 
 Adipogenic differentiation. When grown in adipogenic 
medium, hASCs from the 3 fractions showed clear-cut dif-
ferences, as revealed by Oil Red-O staining and quantifi ca-
tion ( Fig. 5A ). CD34 + and L-NGFR + cells showed signifi cant 
increments in differentiation ability compared to the PA un-
selected cells (arbitrarily fi xed at 100%): the average incre-
ments were 55% ± 59% ( P = 0.032) and 80% ± 86% ( P = 0.031) 
for CD34 + and L-NGFR + hASCs, respectively ( n = 9). We 
analyzed the modulation of the adipogenic differentiation 
ability of the 3 populations at different periods during cul-
ture:  Figure 5B shows a representative sample of the adipo-
genic potential of PA, CD34 + , and L-NGFR + hASCs isolated 
from a single donor. At early passages (<10 weeks of cul-
ture), the immunoselected populations possessed a greater 
ability to produce lipid droplets in comparison to PA cells. 
At later passages (>10 weeks), the adipogenic ability of the 
immunoselected cells was reduced, even if they still main-
tained greater levels of lipid vacuoles production compared 
to the unselected cells. 
 Osteogenic differentiation. The 3 fractions of hASCs showed 
even more clear-cut differences in their extracellular calci-
fi ed matrix deposition, as determined by Alizarin Red S 
staining and quantifi cation. As shown in  Figure 6A , CD34 + 
and L-NGFR + hASCs showed a signifi cant increase in their 
differentiation ability compared to the PA cells (arbitrarily 
fi xed at 100%): the average increment was +386% ± 288% 
( P = 0.0037) for CD34 + hASCs, and +338% ± 235% ( P = 
0.0024) for L-NGFR + cells ( n = 9). In addition, this difference 
between the immunoselected and the PA hASCs popula-
tions was maintained in the long term, although the cal-
cifi ed matrix deposition strongly decreased for all of them 
during culture, as reported in  Figure 6B where a representa-
tive hASCs sample derived from a single donor is shown. At 
later passages (>10 weeks), the 2 immunoselected popula-
tions behaved quite similarly, maintaining more abundant 
levels of extracellular calcium depots in comparison to PA 
cells. 
 Chondrogenic differentiation assessment. The chondrogenic 
potential of the 3 hASCs populations was evaluated deter-
mining GAGs production in cells differentiated in a pellet cul-
ture condition. The immunopurifi ed populations showed a 
and 24.8% ± 32.3%, respectively). The endothelial-com-
mitted progenitor markers KDR and P1H12 were mainly 
expressed on CD34 + cells (12.2% ± 21.9% and 36% ± 23%, re-
spectively) ( Fig. 1A ). Interestingly, CD34 was always highly 
expressed on L-NGFR + cells, whereas a variable but smaller 
percentage of CD34 + cells expressed the L-NGFR antigen 
(28% ± 34.7%). 
 As shown in  Figure 1B , both CD34 and L-NGFR expres-
sions were progressively down-modulated during culture 
and defi nitively lost within 5–8 weeks. 
 The L-NGFR − and CD34 − populations were also ana-
lyzed. Both fractions showed a strong decrease in stem cell 
markers expression compared to the positive populations: on 
CD34 − cells (CD34 expression: 0.4% ± 0.5%) L-NGFR, KDR, 
and P1H12 positivity diminished to 0.97% ± 0.76%, 0.64% ± 
0.79% and 1.68% ± 1.87%, respectively; on the L-NGFR − cells 
(L-NGFR expression: 0.73% ± 1.1%) CD34, CD117, and CD105 
decreased to 6.75% ± 1%, 7.2% ± 4.5%, and 4.1% ± 3.5%, re-
spectively ( Fig. 2A ). Flow cytometric analysis of a represen-
tative sample is shown in  Figure 2B and  2C . 
 Clonogenic potential 
 The clonogenic potential throughout the time of culture 
was determined in all the 3 populations ( Fig. 3 ). A great vari-
ability was found among different donors. At early passages 
(<10 weeks), we did not observe signifi cant differences among 
the 3 populations: for 10 3 cells, the CFU-F median number was 
254 (range 146–362) in PA cells, 230 (range 132–328) in CD34 + 
cells, and 225 (range 166–285) in L-NGFR + cells ( Fig. 3A ). 
 At late passages, we observed a decrease in the colony-form-
ing ability in all the 3 populations, particularly in PA hASCs. 
Indeed, between 10 and 20 weeks, the median number of PA 
colonies strongly decreased to 37 (range 24–56) and was signif-
icantly lower in comparison to L-NGFR + cells (CFU-F median 
number: 118, range 72–144;  P = 0.04), while CD34 + cells me-
dian number was 87 (range 56–118) ( Fig. 3B ). After 20 weeks of 
culture, PA ability to form colonies nearly disappeared (CFU-F 
median number: 3, range 1–5) and was signifi cantly lower in 
comparison to both CD34 + (52, range 30–74;  P = 0.04) and 
L-NGFR + cells (88, range 30–114;  P = 0.03) ( Fig. 3C ). 
 Proliferation ability 
 To characterize and compare the expansion ability of 
the different fractions, the cells were maintained in cul-
ture until senescence. The expansion rates varied widely 
among samples from different donors and exhausted 
within 20–25 weeks of culture. Differences in proliferation 
ability among the 3 fractions were not statistically signifi -
cant, but in the long period PA cells showed a marked re-
duction in their dividing potential in comparison to the 
immunoseparated cells. In fact, both CD34 + and L-NGFR + 
fractions showed high increments in cell proliferation 
when compared to PA: PA median fold increase (F.I.) was 
39.13 (range 27–70), while the median F.I. versus PA (ar-
bitrarily fi xed as 1) was 6.04 (range 5.91–26.64) and 21.71 
(range 13.22–105.85) for CD34 + and L-NGFR + cells, respec-
tively ( n = 6) ( Fig. 4A ). 
 Morphologic appearance. At early weeks of culture, all the 3 
populations showed the typical fi broblast-like aspect. After 
15–20 weeks, the morphological appearance of the 3 fractions 
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early passages (<10 weeks) L-NGFR + cells produced higher 
amounts of GAGs in comparison to the other 2 fractions. 
However at later passages (>10 weeks), we observed a pro-
gressive decrease in GAGs production with no relevant differ-
ences among the populations. 
similar differentiation potential when compared to PA hASCs, 
arbitrarily fi xed at 100% (CD34 + : +2% ± 35%; L-NGFR + : +22% 
± 50%) ( Fig. 7A ) ( n = 6). In  Figure 7B , we analyzed GAGs pro-
duction in the 3 hASCs populations isolated from a single 
donor and differentiated at different times during culture: at 
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 FIG. 2.  ( A ) Surface marker expression in positive and negative CD34 (left panel) and L-NGFR (right panel) fractions. Data 
are expressed as mean ± SD ( n = 12). ( B and  C ) Flow cytometric analysis of CD34 and L-NGFR positive and negative frac-
tions from a representative sample. The percentages of positive cells are reported in each panel. 
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 FIG. 4.  ( A ) Proliferation ability of immunoseparated frac-
tions. The median fold increase versus PA was 6.04 and 21.71 
for CD34 + and L-NGFR + hASCs, respectively ( n = 6). The fold 
increase was calculated as the fi nal absolute number of cells 
obtained when all of the starting cells expanded to senes-
cence, divided by the starting number of cells, and normal-
ized to PA arbitrarily fi xed at 1. ( B ) Morphologic appearance 
of PA, CD34 + , and L-NGFR + cells at 9th week (upper panel) 
and 18th week (lower panel) of culture (optical microscopy, 
400×) of a female, 38-year-old donor. 
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 FIG. 5.  Assessment of adipogenic differentiation by lipid 
vacuoles quantifi cation. ( A ) Mean increments in lipid drop-
lets formation of the immunoselected populations in re-
spect to PA cells during the fi rst 10 weeks of culture (CD34 + : 
+55% ± 59%, * P = 0.017; L-NGFR + : +80% ± 86%, * P = 0.017) 
( n = 9). ( B ) Quantifi cation of lipid vacuoles in PA, CD34 + , 
and L-NGFR + cells isolated from a representative donor, 
adipose-induced after different periods of culture. 
 Analyzing the DNA content of each pellet to normalize 
the GAGs levels, we found that DNA in PA and CD34 + chon-
drogenic micromasses was about 2-fold higher compared to 
pellets cultured in control medium ( Fig. 7C ), whereas there 
was no signifi cant difference between differentiated and 
undifferentiated L-NGFR + micromasses (*CD34 + chondro 
versus CD34 + control:  P = 0.027 and *PA chondro versus PA 
control:  P = 0.034) ( Fig. 7C ). 
 Interestingly, a signifi cant difference in GAGs produc-
tion among the 3 populations was observed in micromasses 
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 The results of our study show that the immunomagnetic 
sorting of hASCs by L-NGFR and CD34 antibodies allows 
the selection of 2 distinct subpopulations, which are more 
effi cient in clonogenic and differentiative abilities compared 
to the whole population. 
 The enrichment of MSCs by a selection with the L-NGFR 
monoclonal antibody has been previously described in adult 
BM [ 34 ], where it defi nes a subset of cells with high prolif-
erative, clonogenic, and multipotential differentiation ability. 
Recently, Yamamoto et al. [ 47 ] isolated and analyzed L-NGFR + 
cells from mouse subcutaneous adipose tissue, showing that 
the rate of differentiation into adipocytes, osteoblasts, and 
neuronal cells was higher than for L-NGFR − ASCs. 
 In human adipose tissue, L-NGFR and CD34 MoAbs 
were able to identify 2 fractions expressing surface markers 
associated with a primitive phenotype. A high percentage 
of freshly isolated L-NGFR + hASCs expressed the stem cell 
marker CD34 on the cellular membrane and variable but 
consistent expressions of CD117 (c-kit, the stem cell factor 
receptor) and CD105 (SH2). Fresh CD34 + cells showed a 
marked positivity for the endothelial-specifi c markers P1H12 
and KDR, and variable co-expression of L-NGFR. Although 
CD34 is the human surface antigen identifying the popu-
lation of BM hematopoietic stem cells, commonly used as 
a marker in clinical settings [ 48 , 49 ], in our experiments the 
lack of expression of the pan-leukocyte marker CD45 and the 
incapability of hASCs to give rise to hematopoietic colonies 
under specifi c stimuli allows us to exclude the hematopoi-
etic origin of CD34 + adipose stem cells. As already reported, 
Lee et al. [ 50 ] isolated a population of muscle-derived CD34 + 
stem cells able to improve both muscle regeneration and 
bone healing, whereas Garcia-Pacheco et al. [ 51 ] found that 
human decidual stromal cells positive for both CD34 and 
STRO-1 are related to BM stromal precursors. Moreover, ex-
pression of CD34 had been already reported in BM MSCs, 
although it was rapidly lost after in vitro culture [ 34 , 52 , 53 ]. 
Accordingly, we observed that L-NGFR and CD34 expres-
sions are progressively down-modulated during culture, in 
parallel with both the reduction of hASCs clonogenic and 
multi-differentiative ability and the acquisition of a mature 
fi broblast phenotype. The developmentally programmed 
loss of marker expression is reminiscent of what was ob-
served in the case of the CD34 [ 54 ], L-NGFR [ 34 ], and Stro-1 
[ 55 ] antigens on BM MSCs, supporting the hypothesis that 
they are markers of primitive cells. 
 Both immunoseparated cellular fractions showed higher 
proliferative ability throughout the time of culture com-
pared to PA hASCs. Due to the wide interdonor variability, 
differences in proliferation among the fractions are not sta-
tistically signifi cant, but refl ect what previously observed 
in BM MSCs [ 34 ]. In addition, PA cells prematurely showed 
morphological signs of suffering and senescence. 
 At early passages, the clonogenic potential of the 3 popu-
lations was similar, but a signifi cant difference was observed 
at later passages, when the immunoseparated fractions 
longer maintained the ability to form colonies. 
 Adipogenic differentiation ability of PA hASCs was pro-
nounced throughout the time of culture, probably due to a 
precommitment of adipose-derived stem cells. However, dur-
ing the early weeks of culture, adipogenic differentiation was 
statistically different between selected and unselected cells. 
 Differences among the 3 fractions are more evident in 
the osteogenic differentiation: the immunoselected hASCs 
cultured in control medium: indeed, undifferentiated CD34 + 
and L-NGFR + cells produced higher levels of GAGs with 
an increase of +47% ± 32% ( P = 0.007) and +81% ± 90% 
( P = 0.038) ( n = 6), respectively, compared to PA undifferen-
tiated micromasses, arbitrarily fi xed at 1 ( Fig. 7D ). 
 Discussion 
 The potential utility of human adipose tissue as a source 
of adult stem cells for regenerative medical therapies needs 
more stringent isolation procedures and characterization 
both to improve the homogeneity of the population and to 
enhance the reproducibility of the results. 
 Indeed, adipose tissue is a highly heterogeneous tis-
sue: donor-dependent differences have been demonstrated 
in cell yield, proliferation, and differentiation ability, most 
likely infl uenced by age [ 30 , 31–33 ], sex, hormones, body 
mass index (BMI) [ 42 , 43 ], infl ammatory and pathological 
conditions like osteoarthritis and diabetes [ 44 , 45 ]. In addi-
tion, Jurgens et al. [ 46 ] have recently demonstrated that not 
only differences exist among individuals, but also yield and 
functional features of hASCs are affected by the adipose 
tissue-harvesting site. 
 Despite the extensive characterization, there is still a lack 
of specifi c markers and methods to selectively isolate the 
more primitive cells from adipose tissue. 
CD34+ L-NGFR+
0%
 o
f D
iff
e
re
n
tia
tio
n 
In
cr
em
en
ts
 v
s. 
PA
Osteogenic Differentiation
**
**
100
200
300
400
500
600
700
800
A
CD34+
PA
Ab
s 
55
0 
nm L-NGFR+
0.0
< 10 Weeks > 20 Weeks
0.2
0.4
0.6
0.8
1.0
B
10−20 Weeks
 FIG. 6.  Evaluation of osteogenic differentiation by calcifi ed 
extracellular matrix quantifi cation. ( A ) Mean increments in 
calcium deposition of CD34 + and L-NGFR + cells versus PA 
during the fi rst 10 weeks of culture (CD34 + : +386% ± 288%, 
** P = 0.0037; L-NGFR + : +338% ± 235%, ** P = 0.0024) ( n = 
9). ( B ) Modulation of calcifi ed extracellular matrix produc-
tion in PA, CD34 + , and L-NGFR + cells from a representative 
donor, osteocyte-induced after different period of culture. 
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also cells only able to respond to the proliferative stimuli 
provided by the growth factor. 
 Altogether, our data suggest that the selection with anti-
L-NGFR MoAb allows us to obtain a more homogeneous 
and primitive population: the almost total co-expression of 
CD34, the expression of the stem markers CD117 and CD105, 
and the higher proliferative, clonogenic, and differentiative 
potential, in particular at early passages, seem to support 
this observation. The role of L-NGFR in MSCs is still unclear, 
although its expression has been described in BM and in 
other tissues [ 34 , 57 ] and it has been shown to be involved in 
several functions including morphogenesis [ 58–61 ], growth 
factor presentation [ 62 ], and apoptosis in response to NGF 
stimulation [ 63 ]. 
 We observed a higher heterogeneity in CD34 + population, 
with <30% of cells co-expressing L-NGFR and low levels of 
CD117 and CD105 expression. In the last years, some authors 
isolated from human adipose tissue CD34 + /CD31 − cells in-
cluding adipocytes progenitor cells and CD34 + /CD31 + cells 
defi ned as capillary endothelial cells [ 18 , 64 ]. They proposed 
that adipocytes and endothelial cells might share a com-
mon precursor, as also suggested by Planat-Benard et al. 
[ 19 ], which could play a determinant role in the excessive 
development of the adipose tissue by contributing to neo-
vascularization and to the apparent adipocyte hyperplasia. 
showed a clearly higher differentiation ability, particularly 
during the early passages in culture. Despite a common de-
crease in calcium deposition during culture, the selected frac-
tions always maintained higher levels than PA hASCs at fi rst 
passages. 
 All the populations behaved similarly in term of chon-
drogenic ability, even if during the fi rst weeks of culture 
L-NGFR + cells seemed to possess a greater differentiation 
potential. Nevertheless, the immunoselected subpopula-
tions better responded both to the physical stimuli and to 
the ipoxia condition of the 3-dimensional culture, positively 
affecting the chondrogenic differentiation [ 56 ]. Indeed, just 
the 3D condition induced CD34 + and L-NGFR + cells to pro-
duce similar or even higher levels of GAGs than PA hASCs 
cultured in chondrogenic medium. No differences in GAGs 
production were observed between L-NGFR + micromasses 
cultured in control and in chondrogenic medium: this could 
be due to the greater ability of the selected hASCs to respond 
to the 3D physical stimuli that could partially mask the dif-
ferentiative effect of chondrogenic medium. 
 Furthermore, DNA quantifi cation showed a higher pro-
liferative effect of the chondrocyte-inductive TGF-β on PA 
and CD34 + fractions in comparison to L-NGFR + cells, maybe 
depending on the greater heterogeneity of these popula-
tions, which contain primitive cells able to differentiate, but 
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Moreover, Traktuev et al. [ 65 ] recently described a hASCs 
subset (CD34 + /CD140a + /CD140b + /CD31 − /CD45 − /CD117 − /
CD144 − ) with pericytic properties that participate in vas-
cular stabilization by mutual structural and functional 
interactions with endothelial cells, maintaining the ability 
to differentiate into multiple lineages. These evidences sug-
gest that CD34 + hASCs could be preferentially used for bone 
tissue engineering, due to their ability to promote the neo-
vascolarization process, which is known to be a critical point 
in the healing of bone defects. 
 These days, in the fi eld of regenerative medicine, physi-
cians prefer one-step surgical procedures in order to reduce 
patients’ discomfort, risks of pathogens transmission, and 
social costs. In this context, the possibility to rapidly select 
subpopulations of cells more prone to differentiate into a 
specifi c lineage would be very advantageous. 
 In conclusion, our results suggest that both subpopula-
tions could be useful tools in regenerative medicine appli-
cations; nevertheless, best results could be obtained by 
investigating the interaction between immunoselected 
hASCs and specifi c biomaterials, either in a static or in a 
dynamic culture condition, in order to achieve the most 
functional cell-scaffold construct. 
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